nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethambutol—Arthralgia—Mometasone—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Ethambutol—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Ethambutol—Neutropenia—Lisinopril—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Ethambutol—Erythema multiforme—Azathioprine—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Ethambutol—Hepatitis—Leflunomide—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Ethambutol—Vision blurred—Captopril—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Ethambutol—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Ethambutol—Anaphylactic shock—Mometasone—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Ethambutol—Ill-defined disorder—Captopril—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Ethambutol—Pneumonia—Lisinopril—systemic scleroderma	0.00386	0.00386	CcSEcCtD
Ethambutol—Hepatitis—Mycophenolic acid—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Ethambutol—Malaise—Captopril—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Ethambutol—Hallucination—Mycophenolic acid—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Ethambutol—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Lisinopril—systemic scleroderma	0.0038	0.0038	CcSEcCtD
Ethambutol—Erythema multiforme—Leflunomide—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Ethambutol—Neuropathy peripheral—Lisinopril—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Ethambutol—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00376	0.00376	CcSEcCtD
Ethambutol—Anorexia—Mometasone—systemic scleroderma	0.00375	0.00375	CcSEcCtD
Ethambutol—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Ethambutol—Visual impairment—Mycophenolic acid—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Ethambutol—Arthralgia—Captopril—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Ethambutol—Abdominal pain—Pentoxifylline—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Ethambutol—Body temperature increased—Pentoxifylline—systemic scleroderma	0.0036	0.0036	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Mometasone—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Ethambutol—Discomfort—Captopril—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Ethambutol—Paraesthesia—Mometasone—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Ethambutol—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.00352	0.00352	CcSEcCtD
Ethambutol—Confusional state—Captopril—systemic scleroderma	0.00348	0.00348	CcSEcCtD
Ethambutol—Anaphylactic shock—Captopril—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Ethambutol—Hepatitis—Lisinopril—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Ethambutol—Ill-defined disorder—Azathioprine—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Ethambutol—Hallucination—Lisinopril—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Ethambutol—Decreased appetite—Mometasone—systemic scleroderma	0.00342	0.00342	CcSEcCtD
Ethambutol—Thrombocytopenia—Captopril—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Ethambutol—Pneumonia—Mycophenolate mofetil—systemic scleroderma	0.00338	0.00338	CcSEcCtD
Ethambutol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Ethambutol—Malaise—Azathioprine—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Ethambutol—Leukopenia—Azathioprine—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Ethambutol—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Ethambutol—Anorexia—Captopril—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Ethambutol—Vision blurred—Leflunomide—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Ethambutol—Erythema multiforme—Lisinopril—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Ethambutol—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Ethambutol—Pruritus—Pentoxifylline—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Ethambutol—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00322	0.00322	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Ethambutol—Malaise—Leflunomide—systemic scleroderma	0.00315	0.00315	CcSEcCtD
Ethambutol—Arthralgia—Azathioprine—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Ethambutol—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00314	0.00314	CcSEcCtD
Ethambutol—Leukopenia—Leflunomide—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Ethambutol—Body temperature increased—Mometasone—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Ethambutol—Abdominal pain—Mometasone—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Ethambutol—Discomfort—Azathioprine—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Ethambutol—Paraesthesia—Captopril—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Ethambutol—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Ethambutol—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Ethambutol—Dizziness—Pentoxifylline—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Ethambutol—Decreased appetite—Captopril—systemic scleroderma	0.003	0.003	CcSEcCtD
Ethambutol—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.003	0.003	CcSEcCtD
Ethambutol—Hallucination—Mycophenolate mofetil—systemic scleroderma	0.003	0.003	CcSEcCtD
Ethambutol—Malaise—Mycophenolic acid—systemic scleroderma	0.003	0.003	CcSEcCtD
Ethambutol—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Ethambutol—Arthralgia—Leflunomide—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Ethambutol—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Ethambutol—Discomfort—Leflunomide—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Ethambutol—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Ethambutol—Vomiting—Pentoxifylline—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Ethambutol—Lymphadenopathy—Methotrexate—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Ethambutol—Rash—Pentoxifylline—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Ethambutol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Ethambutol—Headache—Pentoxifylline—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Ethambutol—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Ethambutol—Feeling abnormal—Captopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Ethambutol—Arthralgia—Mycophenolic acid—systemic scleroderma	0.00283	0.00283	CcSEcCtD
Ethambutol—Vision blurred—Lisinopril—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Ethambutol—Gastrointestinal pain—Captopril—systemic scleroderma	0.00282	0.00282	CcSEcCtD
Ethambutol—Discomfort—Mycophenolic acid—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Ethambutol—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Ethambutol—Pruritus—Mometasone—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Ethambutol—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Ethambutol—Confusional state—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Ethambutol—Abdominal pain—Captopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Ethambutol—Body temperature increased—Captopril—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Ethambutol—Anorexia—Leflunomide—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Ethambutol—Nausea—Pentoxifylline—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Ethambutol—Malaise—Lisinopril—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Ethambutol—Leukopenia—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Ethambutol—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Ethambutol—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00262	0.00262	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Ethambutol—Anorexia—Mycophenolic acid—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Ethambutol—Paraesthesia—Leflunomide—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Ethambutol—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Ethambutol—Arthralgia—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Ethambutol—Discomfort—Lisinopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Ethambutol—Vomiting—Mometasone—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Ethambutol—Feeling abnormal—Azathioprine—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Ethambutol—Rash—Mometasone—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Ethambutol—Dermatitis—Mometasone—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Ethambutol—Decreased appetite—Leflunomide—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Ethambutol—Confusional state—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Ethambutol—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Ethambutol—Headache—Mometasone—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Ethambutol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Ethambutol—Pruritus—Captopril—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Ethambutol—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Ethambutol—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Ethambutol—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Ethambutol—Neutropenia—Prednisone—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Ethambutol—Abdominal pain—Azathioprine—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Ethambutol—Body temperature increased—Azathioprine—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Ethambutol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Ethambutol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Ethambutol—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Ethambutol—Feeling abnormal—Leflunomide—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Ethambutol—Nausea—Mometasone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Ethambutol—Anorexia—Lisinopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Ethambutol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Ethambutol—Dizziness—Captopril—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Ethambutol—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Ethambutol—Abdominal pain—Leflunomide—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Ethambutol—Body temperature increased—Leflunomide—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Ethambutol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Ethambutol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Ethambutol—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Ethambutol—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Ethambutol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Ethambutol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Ethambutol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Ethambutol—Paraesthesia—Lisinopril—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Ethambutol—Vomiting—Captopril—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Ethambutol—Rash—Captopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Ethambutol—Dermatitis—Captopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Ethambutol—Headache—Captopril—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Ethambutol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Ethambutol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Ethambutol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Ethambutol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Ethambutol—Decreased appetite—Lisinopril—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Ethambutol—Eosinophilia—Methotrexate—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Ethambutol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Ethambutol—Hypersensitivity—Leflunomide—systemic scleroderma	0.0021	0.0021	CcSEcCtD
Ethambutol—Nausea—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Ethambutol—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Ethambutol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Ethambutol—Hallucination—Prednisone—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Ethambutol—Feeling abnormal—Lisinopril—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Ethambutol—Pruritus—Leflunomide—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Ethambutol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Ethambutol—Neutropenia—Methotrexate—systemic scleroderma	0.002	0.002	CcSEcCtD
Ethambutol—Dizziness—Azathioprine—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Ethambutol—Abdominal pain—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Ethambutol—Body temperature increased—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Ethambutol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Ethambutol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Ethambutol—Vomiting—Azathioprine—systemic scleroderma	0.00192	0.00192	CcSEcCtD
Ethambutol—Pneumonia—Methotrexate—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Ethambutol—Rash—Azathioprine—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Ethambutol—Dermatitis—Azathioprine—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Ethambutol—Headache—Azathioprine—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Ethambutol—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Ethambutol—Dizziness—Leflunomide—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Ethambutol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Ethambutol—Vomiting—Leflunomide—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Ethambutol—Hypersensitivity—Lisinopril—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Ethambutol—Dizziness—Mycophenolic acid—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Ethambutol—Rash—Leflunomide—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Ethambutol—Dermatitis—Leflunomide—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Ethambutol—Nausea—Azathioprine—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Ethambutol—Headache—Leflunomide—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Ethambutol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Ethambutol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Ethambutol—Pruritus—Lisinopril—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Ethambutol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Ethambutol—Rash—Mycophenolic acid—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Ethambutol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Ethambutol—Hepatitis—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Ethambutol—Headache—Mycophenolic acid—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Ethambutol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Ethambutol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Ethambutol—Nausea—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Ethambutol—Vision blurred—Prednisone—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Ethambutol—Ill-defined disorder—Prednisone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Ethambutol—Visual impairment—Methotrexate—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Ethambutol—Dizziness—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Ethambutol—Erythema multiforme—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Ethambutol—Nausea—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Ethambutol—Malaise—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Ethambutol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Ethambutol—Vomiting—Lisinopril—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Ethambutol—Rash—Lisinopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Ethambutol—Dermatitis—Lisinopril—systemic scleroderma	0.00154	0.00154	CcSEcCtD
Ethambutol—Headache—Lisinopril—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Ethambutol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Ethambutol—Arthralgia—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Ethambutol—Discomfort—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Ethambutol—Nausea—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Ethambutol—Anaphylactic shock—Prednisone—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Ethambutol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Ethambutol—Vision blurred—Methotrexate—systemic scleroderma	0.0014	0.0014	CcSEcCtD
Ethambutol—Anorexia—Prednisone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Ethambutol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Ethambutol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Ethambutol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Ethambutol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Ethambutol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Ethambutol—Malaise—Methotrexate—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Ethambutol—Leukopenia—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Ethambutol—Paraesthesia—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Ethambutol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Ethambutol—Arthralgia—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Ethambutol—Decreased appetite—Prednisone—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Ethambutol—Discomfort—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Ethambutol—Confusional state—Methotrexate—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Ethambutol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Ethambutol—Feeling abnormal—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Ethambutol—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Ethambutol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Ethambutol—Anorexia—Methotrexate—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Ethambutol—Body temperature increased—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Ethambutol—Abdominal pain—Prednisone—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Ethambutol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Ethambutol—Paraesthesia—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Ethambutol—Hypersensitivity—Prednisone—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Ethambutol—Decreased appetite—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Ethambutol—Pruritus—Prednisone—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Ethambutol—Feeling abnormal—Methotrexate—systemic scleroderma	0.001	0.001	CcSEcCtD
Ethambutol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000993	0.000993	CcSEcCtD
Ethambutol—Dizziness—Prednisone—systemic scleroderma	0.000961	0.000961	CcSEcCtD
Ethambutol—Body temperature increased—Methotrexate—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Ethambutol—Abdominal pain—Methotrexate—systemic scleroderma	0.00096	0.00096	CcSEcCtD
Ethambutol—Vomiting—Prednisone—systemic scleroderma	0.000924	0.000924	CcSEcCtD
Ethambutol—Rash—Prednisone—systemic scleroderma	0.000916	0.000916	CcSEcCtD
Ethambutol—Dermatitis—Prednisone—systemic scleroderma	0.000915	0.000915	CcSEcCtD
Ethambutol—Headache—Prednisone—systemic scleroderma	0.00091	0.00091	CcSEcCtD
Ethambutol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000894	0.000894	CcSEcCtD
Ethambutol—Nausea—Prednisone—systemic scleroderma	0.000863	0.000863	CcSEcCtD
Ethambutol—Pruritus—Methotrexate—systemic scleroderma	0.000859	0.000859	CcSEcCtD
Ethambutol—Dizziness—Methotrexate—systemic scleroderma	0.000803	0.000803	CcSEcCtD
Ethambutol—Vomiting—Methotrexate—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Ethambutol—Rash—Methotrexate—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Ethambutol—Dermatitis—Methotrexate—systemic scleroderma	0.000765	0.000765	CcSEcCtD
Ethambutol—Headache—Methotrexate—systemic scleroderma	0.000761	0.000761	CcSEcCtD
Ethambutol—Nausea—Methotrexate—systemic scleroderma	0.000721	0.000721	CcSEcCtD
